Literature DB >> 14569379

[Diagnosis of erectile dysfunction--what is still needed today?].

W-H Weiske1.   

Abstract

Diagnostic procedures for erectile dysfunction (ED) are still mandatory because ED can be the presenting symptom for a variety of diseases such as diabetes mellitus, coronary artery disease, atherosclerosis, hypertension and hyperlipidemia. Invasive testing for ED has decreased due to the high responder rate for oral PDE-5 inhibitors.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14569379     DOI： 10.1007/s00120-003-0420-6

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  12 in total

Review 1.  First international conference on the management of erectile dysfunction. Overview consensus statement.

Authors:  J F Eid; A Nehra; K E Andersson; J Heaton; R W Lewis; A Morales; R B Moreland; J J Mulcahy; H Porst; J L Pryor; I D Sharlip; G Wagner; M Wyllie
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

2.  Single potential analysis of corpus cavernosum electromyography for the assessment of erectile dysfunction: provocation, reproducibility and age dependence--findings in 36 healthy volunteers and 324 patients.

Authors:  M Fabra; A Frieling; H Porst; E Schneider
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

3.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

Authors:  R C Rosen; A Riley; G Wagner; I H Osterloh; J Kirkpatrick; A Mishra
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

Review 4.  The process of care model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel.

Authors: 
Journal:  Int J Impot Res       Date:  1999-04       Impact factor: 2.896

5.  Analysis of continuous nocturnal penile rigidity measurements with the use of the RigiScan summary analysis software program.

Authors:  R F Kropman; R J Tegelaar; A H Zwinderman; A A Lycklama A Nijeholt; W Meinhardt; J Zwartendijk
Journal:  Int J Impot Res       Date:  1995-06       Impact factor: 2.896

6.  Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.

Authors:  A Nehra; M L Blute; D M Barrett; R B Moreland
Journal:  Int J Impot Res       Date:  2002-02       Impact factor: 2.896

Review 7.  Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.

Authors:  J Buvat; A Lemaire
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

8.  Diagnostic evaluation of erectile dysfunction in the era of oral therapy.

Authors:  I D Sharlip
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

9.  Diagnostic steps in the evaluation of patients with erectile dysfunction.

Authors:  Dimitrios Hatzichristou; Konstantinos Hatzimouratidis; Michael Bekas; Apostolos Apostolidis; Vasilios Tzortzis; Konstantinos Yannakoyorgos
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

Review 10.  The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience.

Authors:  H Porst
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.